The 47th Annual Meeting of the

European Diabetes Epidemiology Group

12th – 15th May 2012

Swansea, Wales, UK



 Saturday 12th May


Place:    The Village Hotel


12.00     Registration opens  (Lunch provided in The Hub)


14.45     Opening introductions


15.00     Plenary session 1 : Professor Andrew Morris  - Diabetes Epidemiology in the Informatics Age


15.30     Oral Presentations Session 1 : Epidemiology of Diabetes using Routine Data and Survey Data. (7 presentations)

 15.30-15.45  - Association of diabetes in pregnancy with offspring obesity.  Kelly Morgan, Swansea University, UK

 15.45-16.00- Pregnancy outcomes in women with diabetes in Latvia, 2005-2009. Leva Strele, Riga Stradins University, Latvia.

 1600-16.15 – Factors affecting birth weight in offspring of mothers with type 1 and type 2 diabetes. Ruth Bell. Newcastle University, UK.


16.15-16.45     Coffee Break


16.45-17.00- Type 2 diabetes, cancer risk and socioeconomic status in Scotland (2001-2007), Jeremy Walker, University of Edinburgh, UK

 17.00-17.15- All cause mortality rates in patients with type 2 diabetes compared with the non-diabetic population from Denmark 2001-2010.  Marit Eika Jørgensen, Steno Diabetes Centre, Denmark.

 17.15-17.30 - Socioeconomic status and cardiovascular mortality in people with type 2 diabetes mellitus in Scotland. Nicholas Jones, University of Edinburgh, UK.

 17.30-17.45 Incidence of diagnosed diabetes in persons aged between 40 and 90 years in Germany. Ralph Brinks. Institute of Biometry and Epidemiology, Duesseldorf, Germany.


18.00 – 18.30  Epidemiology of Diabetes using Routine Data: Poster Session (5 posters- 5 minutes each)

 18.00-18.05  Renal replacement therapy rates in those with stage 5 Chronic Kidney Disease in a nationwide study of people with diabetes. Inez Brady, Dundee University, UK.

 18.05-18.10- AEQUITAS: A project on inequality and quality of regional clinical pathways in diabetes management.  Francesca Piraccini, Universita Politecnicà delle Marche, Italy.

 18.10-18.15 Risk factors for complications of type 1 diabetes: A nationwide comparison. Eleanor Hothersall, Dundee University, UK.

 18.15-18.20- The impact of ethnicity on survival in adults with diabetes: a prospective population based cohort study. AC Felix Burden. Birmingham and Solihull NHS Cluster, UK.

 18.20-18.25 Early-Life exposure to the Ukraine Famine of 1933 and the risk of type 2 diabetes in adulthood. Institute of Gerontology, Kiev, Ukraine.

  19.00     Walk to National Waterfront or buses


Place :   National Waterfront Museum

19.30     Welcome Reception and Dinner


Sunday 13th May 


Place:    The Marriott Hotel                                                 

09.00     Plenary Session 2 : Professor Nick Wareham  – Studying Gene-lifestyle Interactions in Type 2 Diabetes

09.30     Oral Presentations Session 2 : Genes and Lifestyle in Diabetes Epidemiology.

9.30-9.45. The association of the mitochondrial DNA 16184-16193 poly-C tract variant with type 2 diabetes. Zheng Ye. MRC Epidemiology Unit, Cambridge, UK.

9.45-10.00 Awareness of physical activity in individuals with newly diagnosed type 2 diabetes: Cross-sectional analysis of the Addition-plus cohort. Gráinne Long, MRC Epidemiology Unit, Cambridge, UK

10.00-10.15 Patterns of physical activity in an adult population: A latent class analysis approach. Anne-Louise Hansen. Steno Diabetes Centre, Denmark.

10.15-10.45     Coffee

10.45-11.00 Intake of dairy products in relation to glucose metabolism in the Danish Inter99 study. A. Heraclides, Steno Diabetes Centre, Denmark.

11.00-11.15 Factors associated with childhood obesity: A school based survey. Sinead Brophy, Swansea University, UK.

11.15-11.30  A lifestyle intervention to reduce type 2 diabetes risk in dutch primary care: 2.5 year results of a randomized controlled trial. Paulina WA Vermunt, University of Tilburg, the Netherlands.

11.45-12.30     (Parallel session) Poster Session 2 : Genes and Lifestyle in Diabetes Epidemiology (8 posters 5 minutes each)

11.45-11.50 Quantifying physical activity energy expenditure using combined heart rate and accelerometry in severely obese individuals: a feasibility study. FM Finucane. Galway University Hospital, Ireland.

11.50-11.55 Maternal Blood Glucose and objectively measured physical activity. Louise Hayes, Newcastle University, UK.

11.55-12.00 Health related quality of life, subjective health complaints, psychological distress and coping in Pakistani immigrant women with and without the metabolic syndrome. The Invadiab-Deplan Study. Victoria Telle Hjellset, University of Oslo, Norway.

12.00-12.05 The effect of genotype-drug interaction on disease risk factors. Marie Bækvad-Hansen, Steno Diabetes Centre, Denmark.

12.05-12.10 Common genetic variants and type 2 diabetes mellitus in an urban Ghanaian population. Ina Danquah, University Medicine Berlin, Germany.

12.10-12.15 Are the associations between metabolic and lipid parameters and breast cancer risk due to confounding by BMI? Mark S Pearce, Newcastle University, UK.

12.15-12.20 On the mean age at diagnosis and duration of type 2 diabetes. Sandra Landwehr, German Diabetes Centre, Germany.

12.20-12.25 Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetes patients: the EURODIAB Prospective Complications Study, DAJM Schoenaker, Wageningen University, Netherlands.  

11.45     (Parallel session) Poster Session 3: Diabetes prediction and epidemiology (8 posters)

11.45-11.55 Clinical indicators of diabetes in Kenya: the development and validation of a ‘clinimetric’ symptom scale in diabetes individuals. Ditte J Rasmussen,  University of Copenhagen, Denmark.

11.55-12.00 Association between HMGB1 and Glucose levels. Troels Mygind Jensen, Steno Diabetes Centre, Denmark.

12.00-12.05 The association between adult height and mortality is explained by short stature in early childhood. Ken Ong, MRC Epidemiology Unit, UK.

12.05-12.10 Screening for type 2 diabetes and abnormal glucose tolerance in Moscow County. IV Misnikova, Moscow Regional Research Clinical Institute, Russia

12.10-12.15 Body composition in Ethiopian infants: role of birth weight and growth velocity. Gregers Andersen, University of Copenhagen, Denmark.

12.15-12.20 Comparison of risk score for detection of type 2 diabetes mellitus in children and young adult using Indian diabetes risk score. A Pranita. Bharati Vidyapeeth Deemed University Medical College, India.

12.20-12.25 Evaluation improvement of diabetes prediction models. The impact of risk cut-offs and number of risk categories on the net reclassification improvement. Kristin Mühlenbruch, German Institute of Human Nutrition Potsdam-Rehbruecke, Germany.

12.25-12.30 Post glucose-load hypoglycaemia is not associated with increased risk for future development of type 2 diabetes. The DEPLAN study. Stavros Liatis, Greece


12.30     Lunch

13.30     General Assembly

14.30     Social Programme 


19.30     Dinner  


Place:    Morgans Hotel

 Monday  14th May                                                                                             

 Place:    The Village


09.00     Plenary session 3 : Professor Marta Garaulet- Title: Sleep, chronobiology and diabetes

 09.30     Oral Presentations : Risk factors for type 2 diabetes. (6 presentations)

 9.30-9.45 HBA1c, fasting and 2-hour plasma glucose in smokers, ex-smokers and non-smokers: A Meta-Analysis. Dominique Simon, Inserm, France.

 9.45-10.00 Associations between general and central obesity measures and type 2 diabetes risk in Sub-Saharan Africans. Laura Schulken, Department of Molecular Epidemiology, Germany.

 10.00-10.15 Visualisation of the effect of BMI adjustement on long term glucose trajectories: multilevel analysis from the Whitehall II study. Adam Hulman, University of Szeged, Hungary.


10.15 -10.45    Coffee Break

 10.45-11.00 Progression to type 2 diabetes in the Whitehall II study: evidence for different subtypes. Kristine Færch, Steno Diabetes Centre, Denmark.

 11.00-11.15 Association of myeloperoxidase and oxidized LDL concentrations in serum with incident type 2 diabetes mellitus: results from the Monica/Kora Augsburg Study. University of Ulm Medical Centre, Germany.

 11.15-11.30 Liver function tests and the risk prediction of type 2 diabetes. Ali Abbasi, University Medical Centre Groningen, the Netherlands.

 11.45     Poster Session 4: Complications of diabetes (7 posters)

 11.45-11.50 Social, demographic, clinical characteristics and metabolic control of young people affected by type 1 diabetes in Italy. Edlira Skrami,  Universita Politecnica delle Marche, Italy.

 11.50-11.55 Integrating chronic diabetes care by bundled payments: results on quality of care and care delivery process after three years. Caroline A Baan, National Institute for Public Health and the Environment, the Netherlands.

 11.55-12.00 Screening for thyroid disease in patients with diabetes. A Mallipedhi, Morriston Hospital, Swansea, UK

 12.00-12.05 Hospitalisations of people with diabetes in France- the 2007 Entred Survey. Frank A Assogba. French Institute for Public Health Surveillance, France.

 12.05-12.10 Cardiovascular and diabetes risk assessment and management in the workplace. James Thornton, Swansea University, UK

 12. 10-12.15 Cardiovascular risk factors in relation to blood glucose in three ethnic populations in rural Kenya. Louise Birkegaard, University of Copenhagen, Denmark

 12.15-12.20 Type 2 diabetes patients acceptance of long-term pharmaco-therapy. Majken Linnemann Jensen, Steno Diabetes Centre, Denmark.

 12.30     Lunch (in the Hub)


 14.00     Plenary session 4  : Professor Anne-Katrina Sjølie  - The Epidemiology of Diabetic Retinopathy in Type 1 Diabetes - Long-term results from Danish Studies


 14.30     Oral Presentations Session 4: Complications of diabetes – Type 1 (6 presentations)

 14.30-14.45  Predicting severe complications in type 1 diabetes patients: development and validation of a predication rule in large cohort studies from Europe and United States.  Sabita Soedamah-Muthu, Wageningen University, the Netherlands.

 14.45-15.00 Type 1 diabetes increases cerebrovascular disease similarly in men and women. Shona Livingstone, Dundee University, UK

 15.00-15.15 Predictors of coronary artery disease in type 1 diabetes (T1D) differ by level of glycemic control and microalbuminuricstatus. Trevor Orchard, University of Pittsburgh, USA.

 15.15-15.30  Concentrations of vitamins A and E in relation to end-stage renal disease in type 1 diabetes. Tina Costacou. University of Pittsburgh, USA.

 15.30-15.45 Infant exposures and development of type 1 diabetes. The Diabetes autoimmune study in the young (DAISY). Brittni Frederisksen,  Colordado School of Public Health, USA.

 15.45-16.00- Rising haemoglobin A1C in the non-diabetic range accelerates time to development of type 1 diabetes in high risk relatives. Kendra Vehik, University of South Florida, USA.

 16.00-16.30     Coffee Break

 16.30     Oral presentations 5 :  Complications and treatment of diabetes (6 presentations)

 16.30-16.45 Clinical distal sensorimotor polyneuropathy in the older German population: the Kora F4 study. Brenda Bongaerts, German Diabetes Centre, Dusseldorf, Germany.

 16.45-17.00 Diabetes is a risk factor for tuberculosis in the Inuit population of Greenland. Stine Byberg, Steno Diabetes Centre, Denmark.

 17.00-17.15 Impact of diabetes drugs on hip fracture risk in those with type 2 diabetes. Helen Colhoun, University of Dundee, UK.

 17.15-17.30 Modelling integrated care for diabetes based on observational data: the Macado Model. Amber AWA van der Heijden. University Medical Centre Groningern,The Netherlands.